COMPARATIVE STUDY
JOURNAL ARTICLE
META-ANALYSIS
WEBCASTS
Add like
Add dislike
Add to saved papers

Is boldness relevant to psychopathic personality? Meta-analytic relations with non-Psychopathy Checklist-based measures of psychopathy.

Two recent meta-analyses have suggested that boldness, as assessed by the Psychopathic Personality Inventory (PPI) Fearless Dominance dimension, is largely unrelated to total or factor scores on the Psychopathy Checklist-Revised (PCL-R), raising questions concerning the relevance of largely adaptive features to psychopathy. Nevertheless, given that the PCL was developed and validated among prisoners, it may place less emphasis than do other psychopathy measures on adaptive traits, such as fearlessness, social poise, and emotional resilience. We conducted a meta-analysis (N = 10,693) of the relations between (a) boldness, as assessed by the PPI and its derivatives or measures of the triarchic model of psychopathy, and (b) non-PCL-based psychopathy measures across 32 samples. The average weighted correlation between boldness and psychopathy was medium to large (r = .39) and considerably higher than reported in prior meta-analyses; when analyses were restricted to well-validated psychopathy measures, the correlation rose to r = .44. We did not find support for the position that boldness is significantly less related to psychopathy than are the other 2 dimensions of the triarchic model. Our findings strongly suggest that boldness is relevant to at least some well-validated measures of psychopathy, and raise further questions regarding the boundaries of this condition. (PsycINFO Database Record

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app